Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

HMPL-453 enters phase II study for advanced intrahepatic cholangiocarcinoma

Sep. 3, 2020

FDA approves Onureg for continued treatment of AML in first remission

Sep. 2, 2020

Novartis AG patents IKZF2 degradation inducers

Sep. 2, 2020

HH-2853 enters first-in-human study for NHL and advanced solid tumors

Sep. 1, 2020

Maruho identifies new BRD4 inhibitors

Sep. 1, 2020

Merck KGaA synthesizes new KIT mutant inhibitors

Sep. 1, 2020

Immutep and Monash University receive grant from ARC to extend their LAG-3 project

Sep. 1, 2020

IIIM-290 development for treating pancreatic cancer advances into the clinic

Aug. 31, 2020

Skyhawk Therapeutics identifies small molecule splicing modulators for cancer

Aug. 31, 2020

Janssen Biotech patents DHODH inhibitors

Aug. 31, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...